Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymp
| Image |  |
|---|---|
| Description | scientific article published on 19 October 2018 |
| Author/s |
author: Jie Jin Tadeusz Robak Franco Cavalli |
| Publication date | October 19, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |